Data / Research funding / Vaccine Related (AIDS)

Vaccine Related (AIDS): 138 NIH awards ($649.5M) to 71 organizations

Name: NIH and NSF awards on Vaccine Related (AIDS)
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

138 NIH awards ($649.5M) in the NIH spending category Vaccine Related (AIDS), to 71 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Vaccine Related (AIDS)Watch Vaccine Related (AIDS)

Topic: NIH spending category

Awards

138 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$417,904,831	August 15, 2023	August 14, 2024	STROKES, BAMBRA	reporter.nih.gov
NIAID CLINICAL SITE MONITORING	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$68,539,045	February 1, 2023	January 31, 2024	SMITH, KIMBERLY	reporter.nih.gov
PDB MANAGEMENT BY THE RESEARCH COLLABORATORY FOR STRUCTURAL BIOINFORMATICS	NIH	National Institute of General Medical Sciences	2021 to 2023	$12,006,722	August 1, 2019	September 18, 2024	BURLEY, STEPHEN K	reporter.nih.gov
Consortia for Innovative AIDS Research in Nonhuman Primates	NIH	National Institute of Allergy and Infectious Diseases	2021	$8,268,168	May 1, 2016	April 30, 2022	BAROUCH, DAN H.	reporter.nih.gov
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection - Administrative Supplement	NIH	National Institute of Allergy and Infectious Diseases	2021	$6,714,942	June 1, 2016	May 31, 2022	HUNTER, ERIC	reporter.nih.gov
Nonhuman Primate (NHP) Core Cellular Immunology Laboratory for AIDS Vaccine Research Development	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$5,634,048	June 1, 2023	May 31, 2024	KAUR, AMITINDER	reporter.nih.gov
Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$4,257,922	April 1, 2021	June 30, 2023	ANDRABI, RAIEES AHMAD	reporter.nih.gov
Novel nanoparticulate adjuvants to enhance HIV-1 Env specific mucosal antibody responses	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$3,234,356	July 3, 2019	June 30, 2025	KASTURI, SUDHIR PAI	reporter.nih.gov
Structure and immunogenicity of novel trimeric HIV-1 Env immunogens	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$3,119,393	September 19, 2019	August 31, 2025	KONG, XIANGPENG	reporter.nih.gov
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,993,032	July 4, 2019	June 30, 2025	VERKOCZY, LAURENT KARL	reporter.nih.gov
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,913,796	April 9, 2021	March 31, 2024	KHANDHAR, AMIT PRAFUL	reporter.nih.gov
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,907,216	December 1, 2018	August 31, 2024	ZHU, JIANG	reporter.nih.gov
Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,731,401	March 9, 2020	April 30, 2024	ZWICK, MICHAEL B	reporter.nih.gov
Nanoparticle-based development for HIV-1 biomolecule delivery	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,678,779	September 15, 2021	July 31, 2026	HASSELL, THOMAS	reporter.nih.gov
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,624,234	February 20, 2019	July 31, 2024	SATHER, D. NOAH	reporter.nih.gov
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,539,937	September 2, 2020	August 31, 2025	GEORGIEV, IVELIN	reporter.nih.gov
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,533,821	August 1, 2019	August 31, 2025	ZWICK, MICHAEL B	reporter.nih.gov
Assessing ADCC and Fc-mediated Protection against HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,485,258	August 13, 2019	March 31, 2024	EVANS, DAVID T	reporter.nih.gov
Immune engineering of optimized sequential immunization strategies for HIV vaccines	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,349,037	April 1, 2021	March 31, 2024	IRVINE, DARRELL J	reporter.nih.gov
Development of a VesiVax HIV Vaccine Formulation	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$2,294,565	August 1, 2022	July 31, 2024	ON HO, SAM	reporter.nih.gov
Effective CMV-based SIV vaccine regimens for newborn infants via IL-10 modulation	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,246,375	December 1, 2019	November 30, 2024	HARTIGAN-O'CONNOR, DENNIS J.	reporter.nih.gov
Improved RhCMV/SIV vaccine efficacy via IL-10 pathway modulation	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$2,205,549	September 24, 2018	August 31, 2023	HARTIGAN-O'CONNOR, DENNIS J.	reporter.nih.gov
How antigen exposure shapes the subsequent NK cell response to HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,169,459	March 18, 2021	August 2, 2023	PAUST, SILKE	reporter.nih.gov
Combinatorial and computational design of bnAb mRNA vaccines for HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,144,122	April 7, 2021	March 31, 2024	ANDERSON, DANIEL G	reporter.nih.gov
Neonatal Immunity to novel TF SHIVs	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$2,087,672	August 15, 2018	March 13, 2024	WILLIAMS, WILTON B	reporter.nih.gov
Modulating antigenic and immunogenic properties of HIV Env by altering signal sequence	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$2,040,044	March 21, 2019	February 28, 2026	UPADHYAY, CHITRA	reporter.nih.gov
Seattle-Lausanne Clinical Trials Unit	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,995,056	February 1, 2007	March 31, 2022	MCELRATH, MARGARET JULIANA	reporter.nih.gov
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,993,554	July 5, 2019	June 30, 2024	NEMAZEE, DAVID	reporter.nih.gov
Targeting natural killer cells to enhance HIV vaccine responses	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,966,918	August 1, 2019	July 31, 2025	WAGGONER, STEPHEN N.	reporter.nih.gov
N-glycan baiting to target the highly effective HIV Env shield	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,923,596	April 19, 2019	March 31, 2024	WYATT, RICHARD THOMAS	reporter.nih.gov
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants	NIH	National Institute of Dental & Craniofacial Research	2021 to 2022	$1,832,540	September 6, 2018	June 30, 2024	DE PARIS, KRISTINA	reporter.nih.gov
MVA Prime/Novel Trimeric Cyclically Permuted Envelope Protein Boost Vaccines for HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,739,786	August 15, 2019	July 31, 2024	AMARA, RAMA RAO	reporter.nih.gov
HIV-1 Env structure and function assessed by parallel smFRET and cryoET	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,676,246	July 18, 2019	June 30, 2023	MOTHES, WALTHER H	reporter.nih.gov
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,626,756	June 7, 2018	May 31, 2025	HIOE, CATARINA E	reporter.nih.gov
Exploiting the antigenic conservation of the Env trimer apex across primate lentiviral lineages for AIDS vaccine design	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,605,291	August 1, 2001	June 30, 2024	HAHN, BEATRICE H	reporter.nih.gov
Understanding Unconventional CD8+ T cell Responses in Protection from HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,596,397	June 1, 2018	May 31, 2025	SACHA, JONAH B.	reporter.nih.gov
Structural and dynamic traits underlying phenotypic variation in HIV-1 Env	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,593,243	July 2, 2019	June 30, 2025	LEE, KELLY KEISEN	reporter.nih.gov
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$1,539,608	August 15, 2021	June 30, 2023	CHANG, THERESA L	reporter.nih.gov
Supramolecular pediatric HIV vaccine design	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,528,995	April 1, 2019	March 31, 2025	COLLIER, JOEL H	reporter.nih.gov
Modeling of HIF-1-alpha Regulation of B Cell Migration	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,476,672	June 6, 2018	May 31, 2025	ZAND, MARTIN S	reporter.nih.gov
The epigenetic reader BRWD1 in peripheral adaptive immunity	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,463,535	January 10, 2019	December 31, 2024	CLARK, MARCUS RAMSAY	reporter.nih.gov
DCM/Integrin TFH Positioning Cues for Support of the Germinal Center Response	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,463,152	November 1, 2018	October 31, 2024	FOWELL, DEBORAH J	reporter.nih.gov
Chemokines and Lymphoid Tissue Organization and Function	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,409,982	April 1, 1999	August 31, 2024	CYSTER, JASON G	reporter.nih.gov
Neutralizing and non-neutralizing antibody effector functions in HIV infected children	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,402,404	March 7, 2019	July 1, 2022	FOUDA AMOU OU, GENEVIEVE GINY	reporter.nih.gov
The role of antibodies in mother to child HIV transmission	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$1,319,416	March 1, 2008	February 28, 2025	OVERBAUGH, JULIE M.	reporter.nih.gov
Decay Accelerating Factor and B cell Immunity	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,271,250	June 17, 2019	May 31, 2025	DOMINGUEZ-SOLA, DAVID	reporter.nih.gov
Very early plasma cell differentiation	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,202,544	May 25, 2018	April 30, 2024	ALLMAN, DAVID M	reporter.nih.gov
Gamma-2 Herpesviruses as Vaccine Vectors for AIDS	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,167,076	March 15, 2005	November 30, 2022	DESROSIERS, RONALD C	reporter.nih.gov
Glycoantigen evolution targeting antibodies of the PGT 128 lineage	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,085,788	June 1, 2010	November 30, 2024	KRAUSS, ISAAC JONATHAN	reporter.nih.gov
Clinical Research Products Management Center (CRPMC)	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$1,057,244	June 16, 2013	June 15, 2020	RERNGSAMAI-NHE, CARINA	reporter.nih.gov
Glycopeptide-specific helper T cells eliciting protective humoral immunity against HIV - Resubmission	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,047,865	March 10, 2021	September 1, 2022	AVCI, FIKRI Y	reporter.nih.gov
Humoral Immunity by Anergic B cells	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,021,128	July 3, 2018	June 30, 2024	TORRES, RAUL MARTIN	reporter.nih.gov
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$1,015,039	May 4, 2022	November 30, 2023	ANDRABI, RAIEES AHMAD	reporter.nih.gov
Designing and optimizing candidate HIV vaccines and boosting protocols	NIH	National Institute of Allergy and Infectious Diseases	2021	$962,348	November 14, 2016	October 31, 2021	NEMAZEE, DAVID	reporter.nih.gov
A safety switch for an effective HIV-1 vaccine	NIH	National Institute on Drug Abuse	2021	$960,000	April 1, 2017	February 28, 2022	FARZAN, MICHAEL R.	reporter.nih.gov
Approaches to Improve the Efficacy of Prime-boost Immunization against HIV/AIDS	NIH	National Institute of Allergy and Infectious Diseases	2021	$891,161	February 6, 2017	January 31, 2024	HU, SHIU-LOK	reporter.nih.gov
Approaches to inducing broadly neutralizing antibodies with immunogens mimicking steric occlusion of the MPER as configured on the HIV-1virion surface	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$890,000	August 1, 2019	July 31, 2024	KIM, MIKYUNG	reporter.nih.gov
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.	NIH	National Institute of Allergy and Infectious Diseases	2021	$877,087	July 1, 2017	June 30, 2023	DERDEYN, CYNTHIA ANN	reporter.nih.gov
Cell decision underlying B-cell immune responses	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$845,915	February 1, 2018	January 31, 2025	HOFFMANN, ALEXANDER	reporter.nih.gov
New analytic approaches and endpoints in human HIV vaccine correlate studies	NIH	National Institute of Allergy and Infectious Diseases	2022	$792,039	May 17, 2022	April 30, 2024	ACKERMAN, MARGARET E	reporter.nih.gov
Immunity to novel T/F SHIVs: variability in the co-evolution of virus and host immunity	NIH	National Institute of Allergy and Infectious Diseases	2021	$777,026	July 1, 2017	June 30, 2022	KELSOE, GARNETT H	reporter.nih.gov
Targeting CD4 T follicular helper cells for enhancing HIV vaccine induced humoral immunity	NIH	National Institute of Allergy and Infectious Diseases	2021	$773,942	May 12, 2021	April 30, 2023	IYER, SWAMINATHAN SMITA	reporter.nih.gov
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity	NIH	National Institute of Allergy and Infectious Diseases	2021	$761,861	March 15, 2018	February 29, 2024	HOXIE, JAMES A	reporter.nih.gov
Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein	NIH	National Institute of Allergy and Infectious Diseases	2021	$750,826	January 17, 2019	December 31, 2022	SODROSKI, JOSEPH G	reporter.nih.gov
Neutralizing and non-neutralizing antibody effector functions in HIV infected children	NIH	National Institute of Allergy and Infectious Diseases	2023	$749,233	November 23, 2022	February 28, 2025	FOUDA AMOU OU, GENEVIEVE GINY	reporter.nih.gov
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$747,562	September 1, 2019	August 31, 2024	HO, DAVID D	reporter.nih.gov
Activation of semi-invariant and diverse NKT cells with an adjuvant combination	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$734,240	November 6, 2017	October 31, 2023	LANG, MARK L	reporter.nih.gov
Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection	NIH	National Institute of Allergy and Infectious Diseases	2021	$731,021	July 18, 2012	November 30, 2021	DESROSIERS, RONALD C	reporter.nih.gov
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$728,038	February 9, 2018	January 31, 2024	SINGH, ANKUR	reporter.nih.gov
Impact of the Intestinal Microbiome on HIV/SIV Vaccines	NIH	Office of the Director, National Institutes of Health	2021	$726,413	April 15, 2017	December 31, 2022	BALDRIDGE, MEGAN T	reporter.nih.gov
Novel Recombinant Streptococcus mitis as an Oral Vaccine against HIV/AIDS	NIH	National Institute of Dental & Craniofacial Research	2021	$718,151	July 1, 2017	June 30, 2025	CAYABYAB, MARK	reporter.nih.gov
The role of antibodies in mother to child HIV transmission	NIH	National Institute of Allergy and Infectious Diseases	2021	$659,708	March 1, 2008	March 31, 2022	OVERBAUGH, JULIE M.	reporter.nih.gov
Prevention of HIV-1 transmission by small-molecule CD4-mimetic entry inhibitors	NIH	National Institute of Allergy and Infectious Diseases	2021	$651,658	July 14, 2017	June 30, 2024	MADANI, NAVID	reporter.nih.gov
Rational design and B cell responses of HIV epitope vaccines	NIH	National Institute of Allergy and Infectious Diseases	2021	$638,644	November 1, 2016	October 31, 2022	ZHU, JIANG	reporter.nih.gov
Targeting tonsillar B cells for the induction of effective mucosal immunity to HIV	NIH	National Institute of Dental & Craniofacial Research	2021	$633,200	July 1, 2019	June 30, 2023	KOBIE, JAMES J	reporter.nih.gov
Defining the biological relevance of HIV-1 adaptation to CD4 T cell responses	NIH	National Institute of Allergy and Infectious Diseases	2021	$628,066	June 1, 2017	May 31, 2023	GOEPFERT, PAUL A.	reporter.nih.gov
Characterization of HIV-1 IgA bNAbs and ADCP function	NIH	National Institute of Allergy and Infectious Diseases	2022	$623,828	December 10, 2021	August 31, 2022	WU, XUELING	reporter.nih.gov
Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization	NIH	National Institute of Allergy and Infectious Diseases	2023	$589,260	September 1, 2023	March 31, 2024	STAMATATOS, LEONIDAS	reporter.nih.gov
Complete mapping of immune selection from antibodies to HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$581,480	December 7, 2018	March 31, 2022	BLOOM, JESSE D	reporter.nih.gov
Mapping the germinal center and memory B cell landscape to complex antigens	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$503,164	September 20, 2021	August 31, 2023	ABBOTT, ROBERT KOEHLER	reporter.nih.gov
Design of vaccination strategies to elicit broadly neutralizing antibodies against HIV-1	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$498,000	September 1, 2019	August 31, 2023	ESCOLANO, AMELIA	reporter.nih.gov
NK cell memory subsets and their impact on HIV disease progression and vaccination	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$482,680	August 1, 2022	July 31, 2025	MACHMACH LEGGAT, KAWTHAR	reporter.nih.gov
Immunogenicity of the newly identified V3 crown vulnerable site	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$481,500	July 5, 2022	June 30, 2025	KONG, XIANGPENG	reporter.nih.gov
Antibody quality and germinal center requirements for peroxisomal function in lymphocytes	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$475,750	August 16, 2021	July 31, 2024	BOOTHBY, MARK R	reporter.nih.gov
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$470,736	August 7, 2020	April 1, 2022	MARTINS, MAURICIO DE AGUIAR	reporter.nih.gov
A participant-derived xenograft mouse model to study T-cell-mediated viral control and mRNA vaccine strategies	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$466,125	August 12, 2022	July 31, 2024	JONES, R. BRAD	reporter.nih.gov
A nonhuman primate model to study the immunological effects of feminizing hormone therapy in transgender women	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$453,041	December 1, 2020	April 1, 2022	MARTINS, MAURICIO DE AGUIAR	reporter.nih.gov
Memory T Cell Development and Survival in T Cell Responses of Older Individuals	NIH	National Institute of Allergy and Infectious Diseases	2021	$445,613	April 1, 2017	March 31, 2024	GORONZY, JORG J	reporter.nih.gov
Trained immunity induced by Nef-containing extracellular vesicles	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$444,125	July 12, 2022	June 30, 2024	BUKRINSKY, MICHAEL ILYA	reporter.nih.gov
Pathways modulating memory-like properties in NK cells and their impact on HIV control	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$444,125	August 1, 2022	July 31, 2024	BOSQUE, ALBERTO	reporter.nih.gov
A humanized mouse model for vaginal HIV-1 transmission.	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$433,125	August 20, 2021	July 31, 2024	SHAN, LIANG	reporter.nih.gov
In-Clinic Latanoprost As a Novel Vaccine Adjuvant	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$432,980	May 27, 2021	April 30, 2023	YOU, ZHAOYANG	reporter.nih.gov
Contribution of c-Maf to regulatory B cells and antibody-secreting cells	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$427,625	January 28, 2021	June 30, 2023	PELANDA, ROBERTA	reporter.nih.gov
Enhancement of Human Immune System Development in Mouse Models	NIH	Office of the Director, National Institutes of Health	2022 to 2023	$422,125	July 1, 2022	June 30, 2024	POLUEKTOVA, LARISA Y	reporter.nih.gov
Exploring the Role of Long Noncoding RNAs in Germinal Center B cells	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$410,498	December 1, 2020	November 30, 2023	SHLOMCHIK, MARK J	reporter.nih.gov
GC-Tfh cell differentiation	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$408,375	March 19, 2021	February 29, 2024	HU, HUI	reporter.nih.gov
Cytokine regulation of T follicular helper (Tfh) cell biology	NIH	National Institute of Allergy and Infectious Diseases	2021	$402,500	July 1, 2017	June 30, 2023	LOCCI, MICHELA	reporter.nih.gov
Functional profile to HIV vaccine elicited antibodies in infants	NIH	National Institute of Allergy and Infectious Diseases	2021	$400,688	April 1, 2017	March 31, 2024	POLLARA, JUSTIN JOSEPH	reporter.nih.gov
Role of RACK1 in RAG1 degradation and B cell development	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$400,125	June 16, 2021	May 31, 2024	SWANSON, PATRICK C.	reporter.nih.gov
Broadly neutralizing antibody combinations with single virions in HIV+ plasma	NIH	National Institute of Allergy and Infectious Diseases	2022	$386,250	August 18, 2022	January 22, 2023	RAY, KRISHANU	reporter.nih.gov
TCR signal strength in thymic selection	NIH	National Institute of Allergy and Infectious Diseases	2021	$372,005	December 1, 2016	November 30, 2022	HOGQUIST, KRISTIN A.	reporter.nih.gov
Probing conformational dynamics of HIV-1 Env in real time and in situ during virus entry	NIH	National Institute of Allergy and Infectious Diseases	2022	$370,700	August 1, 2022	July 31, 2024	LU, MAOLIN	reporter.nih.gov
Defining clinically relevant viral epitopes with cow antibodies	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$352,893	September 1, 2017	May 31, 2024	SMIDER, VAUGHN VASIL	reporter.nih.gov
The EV-HIV Assay, a Point-of-Care Lateral Flow Immunoassay to Accurately Identify HIV Infection from Blood-Based Extracellular Vesicles	NIH	National Institute of Allergy and Infectious Diseases	2023	$306,206	September 1, 2023	August 31, 2024	LUKE, KIMBERLY	reporter.nih.gov
Interferon-modulated vaccines against HIV	NIH	National Institute on Drug Abuse	2021 to 2023	$303,869	July 1, 2020	June 30, 2024	PENALOZA, PABLO	reporter.nih.gov
Nanovaccine for eliciting 10E8-like bnAbs against HIV-1	NIH	National Institute of Allergy and Infectious Diseases	2021	$300,000	July 1, 2021	June 30, 2022	REDDY, CHOWDA	reporter.nih.gov
Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine	NIH	National Institute of Allergy and Infectious Diseases	2021	$300,000	July 1, 2021	June 30, 2022	LI, XU	reporter.nih.gov
Preclinical evaluation of HIV-1 envelope immunogens in humanized mice	NIH	National Institute of Allergy and Infectious Diseases	2022	$300,000	July 1, 2022	June 30, 2023	SRIVASTAVA, VIKRAM	reporter.nih.gov
An integrated multiplexed electrochemical platform for the selective detection of viral protein and RNA to differentiate active HIV-1 infection from vaccine induced seropositivity	NIH	National Institute of Allergy and Infectious Diseases	2022	$300,000	July 1, 2022	June 30, 2023	SKRODZKI, DAVID	reporter.nih.gov
VesiVax HIVgp41e Vaccine Design	NIH	National Institute of Allergy and Infectious Diseases	2022	$300,000	July 1, 2022	June 30, 2023	FUJI, GARY	reporter.nih.gov
Development of Replication-Defective HIV as Vaccine Candidate	NIH	National Institute of Allergy and Infectious Diseases	2022	$300,000	July 1, 2022	June 30, 2023	TUNG, FRANK	reporter.nih.gov
FcRider-based Expression and Delivery of Stable Env Immunogens for HIV Vaccines	NIH	National Institute of Allergy and Infectious Diseases	2022	$299,998	July 1, 2022	June 30, 2023	GAO, WENDA	reporter.nih.gov
Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis	NIH	National Institute of Allergy and Infectious Diseases	2023	$299,903	August 1, 2023	July 31, 2024	PRINCE, ROBIN	reporter.nih.gov
The IRIS-HIV assay, a point-of-care, multiplex serological assay to identify HIV Infection and Vaccine-Induced Seropositivity	NIH	National Institute of Allergy and Infectious Diseases	2022	$299,855	July 1, 2022	June 30, 2023	LUKE, KIMBERLY	reporter.nih.gov
Relevance of serum mannosidase resistance to the specificity of oligomannose-targeting antibodies	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$288,341	June 22, 2021	May 31, 2024	PANTOPHLET, RALPH ALPHONSO	reporter.nih.gov
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors	NIH	National Institute of Allergy and Infectious Diseases	2022	$278,475	April 1, 2010	May 31, 2023	VERKOCZY, LAURENT KARL	reporter.nih.gov
Eliciting tyrosine-sulfated neutralizing antibodies recognizing the Env apex	NIH	National Institute of Allergy and Infectious Diseases	2021	$277,500	March 6, 2020	February 28, 2022	FARZAN, MICHAEL R.	reporter.nih.gov
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity	NIH	National Institute of Allergy and Infectious Diseases	2021	$273,212	December 1, 2016	March 31, 2022	PRLIC, MARTIN	reporter.nih.gov
Structure-Based Designs of HIV-1 Immunogens Targeting Germline Precursors of Broadly Neutralizing Antibodies	NIH	National Institute of Allergy and Infectious Diseases	2021	$264,000	March 17, 2021	March 31, 2022	PANCERA, MARIE	reporter.nih.gov
Identification of protective innate immune memory responses against HIV acquisition in the human female genital tract	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$261,250	August 25, 2022	September 1, 2023	RODRIGUEZ GARCIA, MARTA	reporter.nih.gov
Lymph node targeting nanoparticles for HIV Env proteins	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$252,072	August 10, 2022	November 30, 2023	MOUSA, JARROD	reporter.nih.gov
Statistical Methods for Efficacy Trials of Vaccines and Monoclonal Antibodies Against Genetically-Diverse Pathogens	NIH	National Institute of Allergy and Infectious Diseases	2021	$248,674	April 1, 2003	March 31, 2022	GILBERT, PETER B.	reporter.nih.gov
Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection	NIH	National Institute of Allergy and Infectious Diseases	2021	$246,383	August 18, 2017	July 31, 2023	MORRIS, LYNN	reporter.nih.gov
Molecular signatures of broad neutralization in HIV infected children	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$241,500	May 6, 2020	April 30, 2024	WILLIAMS, WILTON B	reporter.nih.gov
Identifying correlates of protection afforded by (Delta)GY SIVmac239 attenuated virus vaccine	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$234,763	December 7, 2016	April 30, 2022	MARX, PRESTON	reporter.nih.gov
Discovery of Novel Epitopes for Antibody Dependent Cell-mediated Cytotoxicity Against HIV-1 Infected Cells	NIH	National Institute of Allergy and Infectious Diseases	2021	$223,125	February 24, 2020	January 31, 2022	DERDEYN, CYNTHIA ANN	reporter.nih.gov
Unbiased visualization of human ASC subsets	NIH	National Institute of Allergy and Infectious Diseases	2021	$221,755	January 1, 2020	June 30, 2022	BORGHESI, LISA	reporter.nih.gov
Structure-Based Designs of HIV-1 Immunogens Targeting Germline Precursors of Broadly Neutralizing Antibodies	NIH	National Institute of Allergy and Infectious Diseases	2022	$220,000	March 17, 2021	February 29, 2024	PANCERA, MARIE	reporter.nih.gov
eCD4-Ig for preventing and treating obstetric HIV infection	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$197,968	August 13, 2020	April 1, 2022	MARTINS, MAURICIO DE AGUIAR	reporter.nih.gov
In vitro and in vivo analysis of susceptibility of Ad26 vector-induced CD4 T cells to HIV/SIV	NIH	National Institute of Allergy and Infectious Diseases	2021	$197,500	March 1, 2020	February 29, 2024	HU, HAITAO	reporter.nih.gov
Vaccination with self-launching RhCMV/SIV DNA vaccine vectors	NIH	National Institute of Allergy and Infectious Diseases	2021	$194,730	March 10, 2020	February 28, 2023	HARTIGAN-O'CONNOR, DENNIS J.	reporter.nih.gov
Defining BCR evolution during immunization	NIH	National Institute of Allergy and Infectious Diseases	2021	$172,916	December 1, 2012	March 31, 2022	STAMATATOS, LEONIDAS	reporter.nih.gov
Studying the Contribution of Env-SpecificAntibodies to Mother to Child Transmission of HIV-1	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$140,621	August 16, 2021	August 15, 2024	YAFFE, ZACHARY A	reporter.nih.gov
Impact of HLA-II Adaptation on CD4 T-cell and Tfh responses in HIV-1 Vaccination	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$123,551	May 1, 2021	December 31, 2023	FILES, JACOB	reporter.nih.gov
Characterization of the human antibody response to a novel neutralizing HIV-1 epitope	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$94,134	July 1, 2021	September 30, 2023	FILSINGER INTERRANTE, MARIA VICTORIA	reporter.nih.gov
Influence of gut virome on bacterial microbiota and vaccine responsiveness in HIV-exposed infants	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$30,995	April 1, 2020	August 31, 2021	BROWN, BRYAN P	reporter.nih.gov
A nonhuman primate model to study the immunological effects of feminizing hormone therapy in transgender women	NIH	National Institute of Allergy and Infectious Diseases	2022	$24,080	December 1, 2020	November 30, 2022	MARTINS, MAURICIO DE AGUIAR	reporter.nih.gov
Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1	NIH	National Institute of Allergy and Infectious Diseases	2021	$1	June 8, 2017	March 31, 2022	LUND, JENNIFER M	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
PPD Development LP	Wilmington, NC	2	$486.4 million	$0
Scripps Research Institute, the	La Jolla, CA	10	$21.1 million	$0
Emory University	Atlanta, GA	5	$12.8 million	$0
Rutgers University New Brunswick	New Brunswick, NJ	1	$12 million	$0
Beth Israel Deaconess Medical Center	Boston, MA	1	$8.3 million	$0
Duke University	Durham, NC	6	$6.4 million	$0
Tulane University of Louisiana	New Orleans, LA	2	$5.9 million	$0
University of California at Davis	Davis, CA	4	$5.4 million	$0
Icahn School of Medicine at Mount Sinai	New York, NY	3	$4.9 million	$0
Massachusetts Institute of Technology	Cambridge, MA	2	$4.5 million	$0
Fred Hutchinson Cancer Research Center	Seattle, WA	8	$4.2 million	$0
University of Pennsylvania	Philadelphia, PA	4	$4 million	$0
Applied Biomedical Science Institute	San Diego, CA	3	$3.6 million	$0
New York University School of Medicine	New York, NY	2	$3.6 million	$0
Vanderbilt University Medical Center	Nashville, TN	2	$3 million	$0
HDT Bio Corporation	Seattle, WA	1	$2.9 million	$0
International Aids Vaccine Initiative	New York, NY	1	$2.7 million	$0
Seattle Children's Hospital	Seattle, WA	2	$2.7 million	$0
University of Washington	Seattle, WA	3	$2.6 million	$0
Molecular Express, Inc.	Rancho Dominguez, CA	2	$2.6 million	$0
University of Wisconsin-Madison	Madison, WI	1	$2.5 million	$0
Scripps Florida	Jupiter, FL	5	$2.4 million	$0
Dana-Farber Cancer Inst	Boston, MA	3	$2.3 million	$0
Fred Hutchinson Cancer Center	Seattle, WA	3	$2.1 million	$0
Cincinnati Childrens Hosp Med CTR	Cincinnati, OH	1	$2 million	$0
University of Miami School of Medicine	Coral Gables, FL	2	$1.9 million	$0
Univ of North Carolina Chapel Hill	Chapel Hill, NC	1	$1.8 million	$0
University of Alabama at Birmingham	Birmingham, AL	4	$1.8 million	$0
Yale University	New Haven, CT	1	$1.7 million	$0
Oregon Health & Science University	Portland, OR	1	$1.6 million	$0
Rbhs-New Jersey Medical School	Newark, NJ	1	$1.5 million	$0
University of Rochester	Rochester, NY	1	$1.5 million	$0
University of Chicago	Chicago, IL	1	$1.5 million	$0
Cornell University	Ithaca, NY	1	$1.5 million	$0
University of Colorado Denver	Aurora, CO	2	$1.4 million	$0
University of California, San Francisco	San Francisco, CA	1	$1.4 million	$0
Columbia University Health Sciences	New York, NY	2	$1.4 million	$0
University of Georgia Research Foundation Inc	Athens, GA	2	$1.3 million	$0
Weill Medical Coll of Cornell Univ	New York, NY	2	$1.2 million	$0
Washington University	Saint Louis, MO	2	$1.2 million	$0
Brandeis University	Waltham, MA	1	$1.1 million	$0
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	3	$1.1 million	$0
Fisher Bioservices, Inc.	Rockville, MD	1	$1.1 million	$0
George Washington University	Washington, DC	2	$888,250	$0
University of California Los Angeles	Los Angeles, CA	1	$845,915	$0
Dartmouth College	Hanover, NH	1	$792,039	$0
University of Oklahoma HLTH Sciences CTR	Oklahoma City, OK	1	$734,240	$0
Georgia Tech Research Corporation	Atlanta, GA	1	$728,038	$0
Nova Southeastern University	Fort Lauderdale-Davie, FL	1	$718,151	$0
University of Texas Med BR Galveston	Galveston, TX	2	$700,664	$0
Intuitive Biosciences, Inc.	Madison, WI	2	$606,061	$0
Neovaxsyn, Inc.	Ames, IA	2	$600,000	$0
Wistar Institute	Philadelphia, PA	1	$498,000	$0
Henry M. Jackson FDN for the Adv Mil/med	Bethesda, MD	1	$482,680	$0
Mayo Clinic Rochester	Rochester, MN	1	$445,613	$0
University of Nebraska Medical Center	Omaha, NE	1	$422,125	$0
Creighton University	Omaha, NE	1	$400,125	$0
University of Maryland Baltimore	Baltimore, MD	1	$386,250	$0
University of Minnesota	Minneapolis, MN	1	$372,005	$0
University of Texas HLTH CTR at Tyler	Tyler, TX	1	$370,700	$0
Northwestern University at Chicago	Chicago, IL	1	$303,869	$0
Zymeron Corporation	Durham, NC	1	$300,000	$0
Vitruvian Bio, LLC	Ellicott City, MD	1	$300,000	$0
Genecure, LLC	Norcross, GA	1	$300,000	$0
Antagen Pharmaceuticals, Inc.	Boston, MA	1	$299,998	$0
Fluid Discovery INC	San Francisco, CA	1	$299,903	$0
Simon Fraser University	Burnaby	1	$288,341	$0
Tufts University Boston	Boston, MA	1	$261,250	$0
Wits Health Consortium (pty), LTD	Parktown	1	$246,383	$0
Stanford University	Stanford, CA	1	$94,134	$0
University of Florida	Gainesville, FL	1	$24,080	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2023	50	$63,404,230	$0
2022	91	$89,126,610	$0
2021	111	$496,938,797	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)	RFA-AI-27-002	NIH	93.855	November 10, 2026	Not listed	Same assistance listing 93.855 as 107 awards here
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)	RFA-AI-27-005	NIH	93.855	November 10, 2026	Not listed	Same assistance listing 93.855 as 107 awards here
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)	PAR-25-370	NIH	93.855	November 16, 2026	$50,000	Same assistance listing 93.855 as 107 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)	PAR-25-369	NIH	93.855	November 18, 2026	Not listed	Same assistance listing 93.855 as 107 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)	PAR-25-371	NIH	93.855	November 18, 2026	Not listed	Same assistance listing 93.855 as 107 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)	PAR-25-379	NIH	93.855	January 7, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
HIV/AIDS Clinical Trials Network Leadership and Operations Centers	RFA-AI-28-001	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
HIV/AIDS Clinical Trials Network Laboratory Centers	RFA-AI-28-002	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
HIV/AIDS Clinical Trials Network Statistical and Data Management Centers	RFA-AI-28-003	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
HIV/AIDS Clinical Trials Network Clinical Trials Units	RFA-AI-28-004	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases	RFA-AI-28-014	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
Immune Tolerance Network (UM1 Clinical Trial Required)	RFA-AI-28-005	NIH	93.855	January 29, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)	RFA-AI-28-012	NIH	93.855	January 29, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)	RFA-AI-28-024	NIH	93.855	February 11, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)	RFA-LM-28-001	NIH	93.855	February 11, 2027	$775,000	Same assistance listing 93.855 as 107 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.855	April 5, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)	PA-27-102	NIH	93.855	April 5, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)	PA-24-176	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)	PA-24-185	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 107 awards here
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)	PA-24-187	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 107 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.